Skip to Content

Ionis Pharmaceuticals

Visit our Website

WHAT WE DO

Ionis Pharmaceuticals - formerly Isis Pharmaceuticals, Inc. - a leader in RNA-targeted drug discovery and development, combines its innovative, cutting edge technology with the latest in genomic information to develop a pipeline of drugs that can offer significant therapeutic benefit to patients.  Ionis has created a product pipeline of over three dozen drugs that are designed to treat patients with cardiovascular, metabolic, neurodegenerative diseases, cancer and other diseases. Ionis is using its unique drug technology to develop medicines that can address severe genetic diseases, such as spinal muscular atrophy, the number one genetic cause of death in infants. Isis is also developing drugs to treat diseases that affect larger patient populations, such as diabetes.

WHY WE CHOSE THE 78 CORRIDOR

Ionis has been a member of the Carlsbad business community for over 20 years, and, in 2011, Isis opened a new corporate headquarters that is designed to support Isis’ activities for another 20 years.  Being located in Southern California, one of the largest biotechnology areas in the United States, means that Ionis has access to a significant number of resources that support the Company’s business needs.  In addition, Ionis benefits from the numerous top-notch research institutions in the area that attract high-quality talent.

FIVE YEARS FROM NOW...

Ionis has invested more than 25 years to create and advance a technology that can create drugs with the potential to offer, for the first time, therapeutic options to patients with diseases that are currently untreatable.  Today, the success of Ionis’ investment and commitment is evident in the broad and robust pipeline of novel drugs Isis is developing.  Over the next five years, Ionis plans to continue to advance the drugs in its pipeline, several of which could reach the market, to add new drugs into clinical development and to broaden and advance its technology.

The 78 Corridor is a diverse mix of enterprising and high-growth industries, including biotechnology, making this corridor an attractive place to live, work and play.  Ionis anticipates that the 78 Corridor will continue to attract dynamic and innovative companies and similar to the recent progress over the last several years, the area will see continued dynamic growth.

Subscribe to Innovate78

Subscribe to EDC Communications